Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon ; volume:10 ; number:1 ; day:1 ; month:7 ; year:2013 ; pages:1-14 ; date:12.2013
Virology journal ; 10, Heft 1 (1.7.2013), 1-14, 12.2013
- Urheber
-
Zekri, Abdel-Rahman N.
- Beteiligte Personen und Organisationen
-
Bahnassy, Abeer A.
Mohamed, Waleed S.
Alam EL-Din, Hanaa M.
Shousha, Hend I.
Zayed, Naglaa
Eldahshan, Dina H.
Abdel-Aziz, Ashraf Omar
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-10-218
- URN
-
urn:nbn:de:1111-2016050112962
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Zekri, Abdel-Rahman N.
- Bahnassy, Abeer A.
- Mohamed, Waleed S.
- Alam EL-Din, Hanaa M.
- Shousha, Hend I.
- Zayed, Naglaa
- Eldahshan, Dina H.
- Abdel-Aziz, Ashraf Omar
- SpringerLink (Online service)
Ähnliche Objekte (12)
Evaluation of health status in patients with hepatitis c treated with and without interferon
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
![α-Interferon-Therapie [Alpha-Interferon-Therapie] bei Kindern mit chronischer Hepatitis B](/assets/placeholder/searchResultMediaNoDigitisedMedia.png)
α-Interferon-Therapie [Alpha-Interferon-Therapie] bei Kindern mit chronischer Hepatitis B
Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin
Ergebnisse der α-Interferon-Behandlung [Alpha-Interferon-Behandlung] bei Patienten mit chronischer Hepatitis-B- und Hepatitis-C-Virus-Infektion
Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case report
The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
Heterogeneity of hepatitis C virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Heterogeneity of hepatitis C-virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Hepatitis-C-Therapie : Management psychiatrischer Nebenwirkungen von Interferon alfa
Evaluation of health status in patients with hepatitis c treated with and without interferon
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
α-Interferon-Therapie [Alpha-Interferon-Therapie] bei Kindern mit chronischer Hepatitis B
Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin
Ergebnisse der α-Interferon-Behandlung [Alpha-Interferon-Behandlung] bei Patienten mit chronischer Hepatitis-B- und Hepatitis-C-Virus-Infektion
Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case report
The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
Heterogeneity of hepatitis C virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Heterogeneity of hepatitis C-virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Hepatitis-C-Therapie : Management psychiatrischer Nebenwirkungen von Interferon alfa
Evaluation of health status in patients with hepatitis c treated with and without interferon
Differential expression of interferon-induced microRNAs in patients with chronic hepatitis C virus infection treated with pegylated interferon alpha
α-Interferon-Therapie [Alpha-Interferon-Therapie] bei Kindern mit chronischer Hepatitis B
Hepatitis C virus eradication improves immediate and delayed episodic memory in patients treated with interferon and ribavirin
Ergebnisse der α-Interferon-Behandlung [Alpha-Interferon-Behandlung] bei Patienten mit chronischer Hepatitis-B- und Hepatitis-C-Virus-Infektion
Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case report
The spectrum of thyroid dysfunction in an Australian hepatitis C population treated with combination Interferon-α2β and Ribavirin
Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha
Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study
Heterogeneity of hepatitis C virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin
Heterogeneity of hepatitis C-virus in genotype 1 patients treated with the combination therapy of pegylated interferon and ribavirin